HIV Drugs Flashcards
Trogarzo
Ibalizumab-uiyk
MOA: Binds to CD4 Cell RECEPTORS
Treats: Multidrug-Resistant HIV-1 infection FAILING from current REGIMEN
FORM: IV Q 14 DAYS (2 weeks)
SE: DIZZINESS
Rash, Diarrhea
INCREASE URIC ACID
Storage: REFRIGERATE
Maraviroc
Selzentry
PERFORM TROPOISM TEST TO SEE IF DRUG WILL WORK BEFORE USING
MOA: Binds to CCR5 co-receptors of HOST CELL
Dose: 300mg BID
150mg BID (if on CPY3A Inhibitors)
- Protease Inhibitors, antifungal azoles, macrolides
600mg BID (if on CYP3A Inducers) - Efavirenz, rifampin, Carbamazepine, Phenobarbital, Phenytoin
DO NOT TAKE ST. JOHNS WORT w/ selzentry
———————————————————————
-BBW: HEPATOTOXICITY
ORTHOSTATIC HYPOTENSION
**INFECTION (55%)
HEART PROBLEMS
CONTRAINDICATION: CrCl< 30mL/min + CYP3A4 Inhibitor
Fuzeon
Enfuvirtide
MOA: gp41 INHIBITOR of viral cell
Form: SUBQ
DOSE: 90mg SQ BID
PRECAUTIONS: Infection
NUCLEOSIDE Reverse Transcriptase Inhibitors (NRTI’s)
ZidovuDINE(AZT, ZDV): Retrovir
Abacavir(ABC): Ziagen
LamivuDINE(3TC): Epivir
EmtricitaBINE(FTC): Emtriva
StavuDINE(d4T): Zerit
Didanosine(ddl): Videx
Tenofovir is an NRTI, however it is a NUCLEOTIDE Reverse transcriptase inhibitor
Mneumonic: ZALES DT
NRTI’s
SIDE EFFECT PROFILE
1) HEADACHE
2) Lactic Acidosis
3) Hepatic steatosis (FATTY LIVER)
4) RENAL
Take w/ or w/o FOOD except didanoSINE
Retrovir
ZidovuDINE (AZT; ZDV)
Forms: 100mg Capsule
300mg TABLET
10mg/ mL PO Syrup
10mg/ mL IV SOLUTION
DOSE: 300mg BID W/O regards to food
——————————————————
**BBW: Myelosuppression (ANEMIA; NEUTROPENIA)
( DIVING INTO THE MARROW)
Lactic acidosis/ Hepatic STEATOSIS (BBW)
MYOPATHY: BBW**
Lipoatrophy: loss of subq fat
HEADACHE most common
Nausea/vomiting
Purple NAIL DISCOLORATION
Ziagen
Abacavir (ABC)
Forms: 300mg TABLETS
SOLUTION
Dose: 300mg BID/ 600mg QD w or w/o FOOD
ONLY USE IF PT IS HLA-B*5701 NEGATIVE
————————————————
Epzicom: ABC + LamivuDINE: QD
TRIZIVIR: ABC+ LamivuDINE+ zidovudine: BID
TRIUMEQ: ABC+Lamivudine+Dolutegravir: QD
————————————————
Epzicom
Abacavir + LamivuDINE
Trizivir
Abacavir + lamivuDINE + zidovuDINE
1 PO BID
TriuMEQ
Abacavir + Lamivudine + dolutegravir
ONCE DAILY
Epivir
LamivuDINE(3TC)
Dose: 150mg BID
300mg BID
(RENAL DOSE ADJUSTMENT < 50)
Side Effects: Lactic acidosis
Hepatomegaly w/ STEATOSIS
HEADACHE
Emtriva
EmtricitaBINE (FTC)
Dose: Emtriva capsules 200mg QD
Emtriva oral sln: 240mg (REFRIGERATE)
Side EFFECTS: Lactic acidosis
Steatosis w/ Hepatomegaly
FLARE-UPS of HEP-B; LFT!!
COMMON: HEADACHE, diarrhea, NAUSEA
Darkening of PALMS and SOLES may resolve over time
Zerit
Stavudine d4T
Form: Capsules
PO SLN
WEIGHT BASED DOSING
> 60kg: 40mg BID
< 60kg: 30mg BID
————————————————-
- *PANCREATITIS**
- *PERIPHERAL NEUROPATHY**
Lactic Acidosis: MORE FREQUENT (CLASS) HEPATIC STEATOSIS (CLASS) HEADACHE (CLASS)
Lipodystrophy: SUBQ FAT WASTING, Central OBESITY, BREAST ENLARGEMENT, BUFFALO HUMP
ViDEX
didanOsine
EYE EXAM NEEDED AFFECTS THE EYES
FORMS: Delayed-Release Tablets
WEIGHT BASED DOSING
Admin: ONLY NRTI THAT NEEDS TO BE TAKEN ON AN EMPTY STOMACHE
————————————————
- *Pancreatitis **
- Avoid ALCOHOL
- Monitor Amylase Q2-3 MONTHS
- n/v/ Abdominal pain
**PERIPHERAL NEUROPATHY
**RETINAL PIGMENTATION: eye exam q 6 mo
Lactic Acidosis
Hepatomegaly w/ steatosis
Viread (TDF)
Vemlidy (TAF)
tenOfOvir
only NRTI that is a nucleoTIDE inhibitor
TAF- LESS Bone/ KIDNEY tox
TDF- lower lipid levels than TAF
————————————————
Tenofovir disoproxil fumarate (TDF) (Viread)
- Treats: HIV/ Hep-B - Tabs & Oral Powder - Dose: Normal renal —> 300mg QD ADJUST AS FNX DECLINES
Precautions: 1) Lactic Acidosis; Hepatic Steatosis 2) **ACUTE renal failure: FANCONI SYNDROME** 3) ***^ OSTEOPOROSIS RISK** 4) Post treatment HEP-B EXACERBATION 5) Hepatic impairment ———————————————-
Tenofovir aladenamide (TAF) (VEMLIDY)
Treats: Chronic hepatitis B
Form: 25mg tablets
Admin: 25mg PO QD w/ FOOD
PRECAUTIONS: Lactic Acidosis
Hepatic steatosis
SIDE EFFECTS OF NRTI’s
ZALES-DT
1) **HEADACHE
2) Lactic Acidosis
3) Hepatomegaly w/ steatosis (FATTY LIVER)
- ddl, d4T, AZT cause the MOST
4) PANCREATITIS & PERIPHERAL NEUROPATHY only with ddl(didanoSINE) & d4T(Stavudine). These pts should AVOID ALCHOHOL**
TDF: RENAL TOXICITY & OSTEOPOROSIS